company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q2,,2014-06-30,2014-08-14 15:59:50+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,49127000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q2,,2014-06-30,2014-08-14 15:59:50+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2416000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q2,,2014-06-30,2014-08-14 15:59:50+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,51543000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q2,,2014-06-30,2014-08-14 15:59:50+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,69000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q2,,2014-06-30,2014-08-14 15:59:50+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,39000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q2,,2014-06-30,2014-08-14 15:59:50+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,39000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q2,,2014-06-30,2014-08-14 15:59:50+00:00,,totalassets,Total Assets,=,debit,usd,51651000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q2,,2014-06-30,2014-08-14 15:59:50+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1862000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q2,,2014-06-30,2014-08-14 15:59:50+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2069000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q2,,2014-06-30,2014-08-14 15:59:50+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,3931000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q2,,2014-06-30,2014-08-14 15:59:50+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,40000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q2,,2014-06-30,2014-08-14 15:59:50+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,40000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q2,,2014-06-30,2014-08-14 15:59:50+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,3971000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q2,,2014-06-30,2014-08-14 15:59:50+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,92472000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q2,,2014-06-30,2014-08-14 15:59:50+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q2,,2014-06-30,2014-08-14 15:59:50+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-44792000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q2,,2014-06-30,2014-08-14 15:59:50+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-44792000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q2,,2014-06-30,2014-08-14 15:59:50+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-44792000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q2,,2014-06-30,2014-08-14 15:59:50+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-44792000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q2,,2014-06-30,2014-08-14 15:59:50+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,51651000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q3,,2014-09-30,2014-11-13 07:17:47+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,136727000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q3,,2014-09-30,2014-11-13 07:17:47+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1063000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q3,,2014-09-30,2014-11-13 07:17:47+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,137790000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q3,,2014-09-30,2014-11-13 07:17:47+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,134000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q3,,2014-09-30,2014-11-13 07:17:47+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,39000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q3,,2014-09-30,2014-11-13 07:17:47+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,39000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q3,,2014-09-30,2014-11-13 07:17:47+00:00,,totalassets,Total Assets,=,debit,usd,137963000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q3,,2014-09-30,2014-11-13 07:17:47+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2157000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q3,,2014-09-30,2014-11-13 07:17:47+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2853000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q3,,2014-09-30,2014-11-13 07:17:47+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,5010000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q3,,2014-09-30,2014-11-13 07:17:47+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,34000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q3,,2014-09-30,2014-11-13 07:17:47+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,34000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q3,,2014-09-30,2014-11-13 07:17:47+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,5044000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q3,,2014-09-30,2014-11-13 07:17:47+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,187403000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q3,,2014-09-30,2014-11-13 07:17:47+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-54484000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q3,,2014-09-30,2014-11-13 07:17:47+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,132919000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q3,,2014-09-30,2014-11-13 07:17:47+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,132919000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q3,,2014-09-30,2014-11-13 07:17:47+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,132919000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q3,,2014-09-30,2014-11-13 07:17:47+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,137963000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,,2015-03-31,2015-05-15 16:23:18+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,113162000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,,2015-03-31,2015-05-15 16:23:18+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1367000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,,2015-03-31,2015-05-15 16:23:18+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,114529000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,,2015-03-31,2015-05-15 16:23:18+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,269000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,,2015-03-31,2015-05-15 16:23:18+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,641000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,,2015-03-31,2015-05-15 16:23:18+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,39000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,,2015-03-31,2015-05-15 16:23:18+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,680000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,,2015-03-31,2015-05-15 16:23:18+00:00,,totalassets,Total Assets,=,debit,usd,115478000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,,2015-03-31,2015-05-15 16:23:18+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2782000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,,2015-03-31,2015-05-15 16:23:18+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5522000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,,2015-03-31,2015-05-15 16:23:18+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,641000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,,2015-03-31,2015-05-15 16:23:18+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,8945000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,,2015-03-31,2015-05-15 16:23:18+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,23000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,,2015-03-31,2015-05-15 16:23:18+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,23000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,,2015-03-31,2015-05-15 16:23:18+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,8968000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,,2015-03-31,2015-05-15 16:23:18+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,,2015-03-31,2015-05-15 16:23:18+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,,2015-03-31,2015-05-15 16:23:18+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,190226000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,,2015-03-31,2015-05-15 16:23:18+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-83716000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,,2015-03-31,2015-05-15 16:23:18+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,106510000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,,2015-03-31,2015-05-15 16:23:18+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,106510000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,,2015-03-31,2015-05-15 16:23:18+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,106510000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,,2015-03-31,2015-05-15 16:23:18+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,115478000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,,2015-06-30,2015-08-12 16:54:25+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,224234000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,,2015-06-30,2015-08-12 16:54:25+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3274000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,,2015-06-30,2015-08-12 16:54:25+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,227508000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,,2015-06-30,2015-08-12 16:54:25+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,285000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,,2015-06-30,2015-08-12 16:54:25+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,641000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,,2015-06-30,2015-08-12 16:54:25+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,39000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,,2015-06-30,2015-08-12 16:54:25+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,680000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,,2015-06-30,2015-08-12 16:54:25+00:00,,totalassets,Total Assets,=,debit,usd,228473000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,,2015-06-30,2015-08-12 16:54:25+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5195000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,,2015-06-30,2015-08-12 16:54:25+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5164000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,,2015-06-30,2015-08-12 16:54:25+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,641000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,,2015-06-30,2015-08-12 16:54:25+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,11000000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,,2015-06-30,2015-08-12 16:54:25+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,22000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,,2015-06-30,2015-08-12 16:54:25+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,22000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,,2015-06-30,2015-08-12 16:54:25+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,11022000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,,2015-06-30,2015-08-12 16:54:25+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,,2015-06-30,2015-08-12 16:54:25+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,,2015-06-30,2015-08-12 16:54:25+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,326194000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,,2015-06-30,2015-08-12 16:54:25+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-108743000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,,2015-06-30,2015-08-12 16:54:25+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,217451000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,,2015-06-30,2015-08-12 16:54:25+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,217451000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,,2015-06-30,2015-08-12 16:54:25+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,217451000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,,2015-06-30,2015-08-12 16:54:25+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,228473000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,,2015-09-30,2015-11-06 15:51:27+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,204877000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,,2015-09-30,2015-11-06 15:51:27+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2604000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,,2015-09-30,2015-11-06 15:51:27+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,207481000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,,2015-09-30,2015-11-06 15:51:27+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,249000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,,2015-09-30,2015-11-06 15:51:27+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,641000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,,2015-09-30,2015-11-06 15:51:27+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,39000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,,2015-09-30,2015-11-06 15:51:27+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,680000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,,2015-09-30,2015-11-06 15:51:27+00:00,,totalassets,Total Assets,=,debit,usd,208410000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,,2015-09-30,2015-11-06 15:51:27+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3246000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,,2015-09-30,2015-11-06 15:51:27+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6404000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,,2015-09-30,2015-11-06 15:51:27+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,641000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,,2015-09-30,2015-11-06 15:51:27+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,10291000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,,2015-09-30,2015-11-06 15:51:27+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,15000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,,2015-09-30,2015-11-06 15:51:27+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,15000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,,2015-09-30,2015-11-06 15:51:27+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,10306000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,,2015-09-30,2015-11-06 15:51:27+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,,2015-09-30,2015-11-06 15:51:27+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,,2015-09-30,2015-11-06 15:51:27+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,330882000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,,2015-09-30,2015-11-06 15:51:27+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-132778000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,,2015-09-30,2015-11-06 15:51:27+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,198104000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,,2015-09-30,2015-11-06 15:51:27+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,198104000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,,2015-09-30,2015-11-06 15:51:27+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,198104000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,,2015-09-30,2015-11-06 15:51:27+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,208410000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,,2016-03-31,2016-05-06 16:18:55+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,299680000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,,2016-03-31,2016-05-06 16:18:55+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2926000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,,2016-03-31,2016-05-06 16:18:55+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,302606000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,,2016-03-31,2016-05-06 16:18:55+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,865000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,,2016-03-31,2016-05-06 16:18:55+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,,2016-03-31,2016-05-06 16:18:55+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,39000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,,2016-03-31,2016-05-06 16:18:55+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,39000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,,2016-03-31,2016-05-06 16:18:55+00:00,,totalassets,Total Assets,=,debit,usd,303510000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,,2016-03-31,2016-05-06 16:18:55+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4540000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,,2016-03-31,2016-05-06 16:18:55+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,11430000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,,2016-03-31,2016-05-06 16:18:55+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,15970000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,,2016-03-31,2016-05-06 16:18:55+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,40000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,,2016-03-31,2016-05-06 16:18:55+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,40000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,,2016-03-31,2016-05-06 16:18:55+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,16010000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,,2016-03-31,2016-05-06 16:18:55+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,,2016-03-31,2016-05-06 16:18:55+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,,2016-03-31,2016-05-06 16:18:55+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,479383000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,,2016-03-31,2016-05-06 16:18:55+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-191883000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,,2016-03-31,2016-05-06 16:18:55+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,287500000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,,2016-03-31,2016-05-06 16:18:55+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,287500000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,,2016-03-31,2016-05-06 16:18:55+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,287500000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,,2016-03-31,2016-05-06 16:18:55+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,303510000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,,2016-06-30,2016-08-09 06:46:58+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,189003000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,,2016-06-30,2016-08-09 06:46:58+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,83292000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,,2016-06-30,2016-08-09 06:46:58+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1812000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,,2016-06-30,2016-08-09 06:46:58+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,274107000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,,2016-06-30,2016-08-09 06:46:58+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,959000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,,2016-06-30,2016-08-09 06:46:58+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,,2016-06-30,2016-08-09 06:46:58+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,564000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,,2016-06-30,2016-08-09 06:46:58+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,564000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,,2016-06-30,2016-08-09 06:46:58+00:00,,totalassets,Total Assets,=,debit,usd,275630000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,,2016-06-30,2016-08-09 06:46:58+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5957000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,,2016-06-30,2016-08-09 06:46:58+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,12382000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,,2016-06-30,2016-08-09 06:46:58+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,18339000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,,2016-06-30,2016-08-09 06:46:58+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,82000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,,2016-06-30,2016-08-09 06:46:58+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,82000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,,2016-06-30,2016-08-09 06:46:58+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,18421000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,,2016-06-30,2016-08-09 06:46:58+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,,2016-06-30,2016-08-09 06:46:58+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,,2016-06-30,2016-08-09 06:46:58+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,483800000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,,2016-06-30,2016-08-09 06:46:58+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-226630000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,,2016-06-30,2016-08-09 06:46:58+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,39000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,,2016-06-30,2016-08-09 06:46:58+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,257209000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,,2016-06-30,2016-08-09 06:46:58+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,257209000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,,2016-06-30,2016-08-09 06:46:58+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,257209000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,,2016-06-30,2016-08-09 06:46:58+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,275630000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,,2016-09-30,2016-11-03 08:31:53+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,320078000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,,2016-09-30,2016-11-03 08:31:53+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,111192000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,,2016-09-30,2016-11-03 08:31:53+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3418000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,,2016-09-30,2016-11-03 08:31:53+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,434688000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,,2016-09-30,2016-11-03 08:31:53+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1049000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,,2016-09-30,2016-11-03 08:31:53+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,,2016-09-30,2016-11-03 08:31:53+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,564000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,,2016-09-30,2016-11-03 08:31:53+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,564000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,,2016-09-30,2016-11-03 08:31:53+00:00,,totalassets,Total Assets,=,debit,usd,436301000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,,2016-09-30,2016-11-03 08:31:53+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5237000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,,2016-09-30,2016-11-03 08:31:53+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,17093000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,,2016-09-30,2016-11-03 08:31:53+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,22330000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,,2016-09-30,2016-11-03 08:31:53+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,234000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,,2016-09-30,2016-11-03 08:31:53+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,234000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,,2016-09-30,2016-11-03 08:31:53+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,22564000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,,2016-09-30,2016-11-03 08:31:53+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,,2016-09-30,2016-11-03 08:31:53+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,,2016-09-30,2016-11-03 08:31:53+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,678198000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,,2016-09-30,2016-11-03 08:31:53+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-264426000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,,2016-09-30,2016-11-03 08:31:53+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-35000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,,2016-09-30,2016-11-03 08:31:53+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,413737000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,,2016-09-30,2016-11-03 08:31:53+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,413737000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,,2016-09-30,2016-11-03 08:31:53+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,413737000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,,2016-09-30,2016-11-03 08:31:53+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,436301000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,,2017-03-31,2017-05-09 19:01:18+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,145460000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,,2017-03-31,2017-05-09 19:01:18+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,197104000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,,2017-03-31,2017-05-09 19:01:18+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,6480000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,,2017-03-31,2017-05-09 19:01:18+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,349044000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,,2017-03-31,2017-05-09 19:01:18+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1560000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,,2017-03-31,2017-05-09 19:01:18+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,564000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,,2017-03-31,2017-05-09 19:01:18+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,564000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,,2017-03-31,2017-05-09 19:01:18+00:00,,totalassets,Total Assets,=,debit,usd,351168000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,,2017-03-31,2017-05-09 19:01:18+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,8230000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,,2017-03-31,2017-05-09 19:01:18+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,23652000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,,2017-03-31,2017-05-09 19:01:18+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,31882000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,,2017-03-31,2017-05-09 19:01:18+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,840000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,,2017-03-31,2017-05-09 19:01:18+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,840000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,,2017-03-31,2017-05-09 19:01:18+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,32722000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,,2017-03-31,2017-05-09 19:01:18+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,,2017-03-31,2017-05-09 19:01:18+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,,2017-03-31,2017-05-09 19:01:18+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,695649000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,,2017-03-31,2017-05-09 19:01:18+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-377105000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,,2017-03-31,2017-05-09 19:01:18+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-17000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,,2017-03-31,2017-05-09 19:01:18+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-81000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,,2017-03-31,2017-05-09 19:01:18+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,318446000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,,2017-03-31,2017-05-09 19:01:18+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,318446000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,,2017-03-31,2017-05-09 19:01:18+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,318446000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,,2017-03-31,2017-05-09 19:01:18+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,351168000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,,2017-06-30,2017-08-03 16:16:21+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,133450000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,,2017-06-30,2017-08-03 16:16:21+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,152478000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,,2017-06-30,2017-08-03 16:16:21+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5192000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,,2017-06-30,2017-08-03 16:16:21+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,291120000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,,2017-06-30,2017-08-03 16:16:21+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1443000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,,2017-06-30,2017-08-03 16:16:21+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,849000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,,2017-06-30,2017-08-03 16:16:21+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,849000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,,2017-06-30,2017-08-03 16:16:21+00:00,,totalassets,Total Assets,=,debit,usd,293412000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,,2017-06-30,2017-08-03 16:16:21+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6042000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,,2017-06-30,2017-08-03 16:16:21+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,26239000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,,2017-06-30,2017-08-03 16:16:21+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,32281000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,,2017-06-30,2017-08-03 16:16:21+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,827000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,,2017-06-30,2017-08-03 16:16:21+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,827000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,,2017-06-30,2017-08-03 16:16:21+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,33108000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,,2017-06-30,2017-08-03 16:16:21+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,,2017-06-30,2017-08-03 16:16:21+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,,2017-06-30,2017-08-03 16:16:21+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,707694000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,,2017-06-30,2017-08-03 16:16:21+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-447306000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,,2017-06-30,2017-08-03 16:16:21+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-17000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,,2017-06-30,2017-08-03 16:16:21+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-67000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,,2017-06-30,2017-08-03 16:16:21+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,260304000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,,2017-06-30,2017-08-03 16:16:21+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,260304000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,,2017-06-30,2017-08-03 16:16:21+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,260304000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,,2017-06-30,2017-08-03 16:16:21+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,293412000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,,2017-09-30,2017-11-02 07:46:14+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,134916000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,,2017-09-30,2017-11-02 07:46:14+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,108535000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,,2017-09-30,2017-11-02 07:46:14+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4892000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,,2017-09-30,2017-11-02 07:46:14+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,248343000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,,2017-09-30,2017-11-02 07:46:14+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1893000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,,2017-09-30,2017-11-02 07:46:14+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,849000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,,2017-09-30,2017-11-02 07:46:14+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,849000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,,2017-09-30,2017-11-02 07:46:14+00:00,,totalassets,Total Assets,=,debit,usd,251085000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,,2017-09-30,2017-11-02 07:46:14+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,13030000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,,2017-09-30,2017-11-02 07:46:14+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,36807000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,,2017-09-30,2017-11-02 07:46:14+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,49837000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,,2017-09-30,2017-11-02 07:46:14+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1196000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,,2017-09-30,2017-11-02 07:46:14+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1196000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,,2017-09-30,2017-11-02 07:46:14+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,51033000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,,2017-09-30,2017-11-02 07:46:14+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,,2017-09-30,2017-11-02 07:46:14+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,,2017-09-30,2017-11-02 07:46:14+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,721109000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,,2017-09-30,2017-11-02 07:46:14+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-521025000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,,2017-09-30,2017-11-02 07:46:14+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-17000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,,2017-09-30,2017-11-02 07:46:14+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-15000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,,2017-09-30,2017-11-02 07:46:14+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,200052000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,,2017-09-30,2017-11-02 07:46:14+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,200052000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,,2017-09-30,2017-11-02 07:46:14+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,200052000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,,2017-09-30,2017-11-02 07:46:14+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,251085000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,,2018-03-31,2018-05-03 07:17:01+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,557555000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,,2018-03-31,2018-05-03 07:17:01+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,525958000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,,2018-03-31,2018-05-03 07:17:01+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,11575000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,,2018-03-31,2018-05-03 07:17:01+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1095088000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,,2018-03-31,2018-05-03 07:17:01+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4295000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,,2018-03-31,2018-05-03 07:17:01+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,1269000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,,2018-03-31,2018-05-03 07:17:01+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1269000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,,2018-03-31,2018-05-03 07:17:01+00:00,,totalassets,Total Assets,=,debit,usd,1100652000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,,2018-03-31,2018-05-03 07:17:01+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,8350000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,,2018-03-31,2018-05-03 07:17:01+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,29522000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,,2018-03-31,2018-05-03 07:17:01+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,37872000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,,2018-03-31,2018-05-03 07:17:01+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,3504000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,,2018-03-31,2018-05-03 07:17:01+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,3504000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,,2018-03-31,2018-05-03 07:17:01+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,41376000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,,2018-03-31,2018-05-03 07:17:01+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,,2018-03-31,2018-05-03 07:17:01+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,,2018-03-31,2018-05-03 07:17:01+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1724717000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,,2018-03-31,2018-05-03 07:17:01+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-665045000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,,2018-03-31,2018-05-03 07:17:01+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-211000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,,2018-03-31,2018-05-03 07:17:01+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-185000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,,2018-03-31,2018-05-03 07:17:01+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1059276000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,,2018-03-31,2018-05-03 07:17:01+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1059276000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,,2018-03-31,2018-05-03 07:17:01+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1059276000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,,2018-03-31,2018-05-03 07:17:01+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1100652000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,,2018-06-30,2018-08-07 07:32:24+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,325830000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,,2018-06-30,2018-08-07 07:32:24+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,766603000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,,2018-06-30,2018-08-07 07:32:24+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,18378000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,,2018-06-30,2018-08-07 07:32:24+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,12958000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,,2018-06-30,2018-08-07 07:32:24+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1123769000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,,2018-06-30,2018-08-07 07:32:24+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4445000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,,2018-06-30,2018-08-07 07:32:24+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,1269000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,,2018-06-30,2018-08-07 07:32:24+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1269000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,,2018-06-30,2018-08-07 07:32:24+00:00,,totalassets,Total Assets,=,debit,usd,1129483000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,,2018-06-30,2018-08-07 07:32:24+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,8338000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,,2018-06-30,2018-08-07 07:32:24+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,39581000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,,2018-06-30,2018-08-07 07:32:24+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,47919000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,,2018-06-30,2018-08-07 07:32:24+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,3801000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,,2018-06-30,2018-08-07 07:32:24+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,3801000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,,2018-06-30,2018-08-07 07:32:24+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,51720000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,,2018-06-30,2018-08-07 07:32:24+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,,2018-06-30,2018-08-07 07:32:24+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,,2018-06-30,2018-08-07 07:32:24+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1760142000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,,2018-06-30,2018-08-07 07:32:24+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-682023000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,,2018-06-30,2018-08-07 07:32:24+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-211000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,,2018-06-30,2018-08-07 07:32:24+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-145000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,,2018-06-30,2018-08-07 07:32:24+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1077763000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,,2018-06-30,2018-08-07 07:32:24+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1077763000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,,2018-06-30,2018-08-07 07:32:24+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1077763000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,,2018-06-30,2018-08-07 07:32:24+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1129483000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,,2018-09-30,2018-11-06 07:55:30+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,253123000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,,2018-09-30,2018-11-06 07:55:30+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,768278000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,,2018-09-30,2018-11-06 07:55:30+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,18511000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,,2018-09-30,2018-11-06 07:55:30+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1039912000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,,2018-09-30,2018-11-06 07:55:30+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5168000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,,2018-09-30,2018-11-06 07:55:30+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,1919000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,,2018-09-30,2018-11-06 07:55:30+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1919000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,,2018-09-30,2018-11-06 07:55:30+00:00,,totalassets,Total Assets,=,debit,usd,1046999000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,,2018-09-30,2018-11-06 07:55:30+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5879000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,,2018-09-30,2018-11-06 07:55:30+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,48647000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,,2018-09-30,2018-11-06 07:55:30+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,54526000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,,2018-09-30,2018-11-06 07:55:30+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,3968000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,,2018-09-30,2018-11-06 07:55:30+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,3968000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,,2018-09-30,2018-11-06 07:55:30+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,58494000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,,2018-09-30,2018-11-06 07:55:30+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,,2018-09-30,2018-11-06 07:55:30+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,,2018-09-30,2018-11-06 07:55:30+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1793914000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,,2018-09-30,2018-11-06 07:55:30+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-804941000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,,2018-09-30,2018-11-06 07:55:30+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-211000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,,2018-09-30,2018-11-06 07:55:30+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-257000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,,2018-09-30,2018-11-06 07:55:30+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,988505000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,,2018-09-30,2018-11-06 07:55:30+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,988505000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,,2018-09-30,2018-11-06 07:55:30+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,988505000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,,2018-09-30,2018-11-06 07:55:30+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1046999000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,,2019-03-31,2019-05-02 07:16:02+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,342295000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,,2019-03-31,2019-05-02 07:16:02+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,1008956000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,,2019-03-31,2019-05-02 07:16:02+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,20281000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,,2019-03-31,2019-05-02 07:16:02+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1371532000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,,2019-03-31,2019-05-02 07:16:02+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,6513000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,,2019-03-31,2019-05-02 07:16:02+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,42502000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,,2019-03-31,2019-05-02 07:16:02+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,2367000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,,2019-03-31,2019-05-02 07:16:02+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,44869000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,,2019-03-31,2019-05-02 07:16:02+00:00,,totalassets,Total Assets,=,debit,usd,1422914000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,,2019-03-31,2019-05-02 07:16:02+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,13556000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,,2019-03-31,2019-05-02 07:16:02+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,47651000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,,2019-03-31,2019-05-02 07:16:02+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,7169000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,,2019-03-31,2019-05-02 07:16:02+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,68376000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,,2019-03-31,2019-05-02 07:16:02+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,35004000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,,2019-03-31,2019-05-02 07:16:02+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,35004000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,,2019-03-31,2019-05-02 07:16:02+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,103380000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,,2019-03-31,2019-05-02 07:16:02+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,,2019-03-31,2019-05-02 07:16:02+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,,2019-03-31,2019-05-02 07:16:02+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,2446775000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,,2019-03-31,2019-05-02 07:16:02+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1126735000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,,2019-03-31,2019-05-02 07:16:02+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-400000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,,2019-03-31,2019-05-02 07:16:02+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-106000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,,2019-03-31,2019-05-02 07:16:02+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1319534000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,,2019-03-31,2019-05-02 07:16:02+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1319534000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,,2019-03-31,2019-05-02 07:16:02+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1319534000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,,2019-03-31,2019-05-02 07:16:02+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1422914000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,,2019-06-30,2019-08-06 07:16:48+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,166185000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,,2019-06-30,2019-08-06 07:16:48+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,1070364000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,,2019-06-30,2019-08-06 07:16:48+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,27021000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,,2019-06-30,2019-08-06 07:16:48+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1263570000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,,2019-06-30,2019-08-06 07:16:48+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,8363000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,,2019-06-30,2019-08-06 07:16:48+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,41247000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,,2019-06-30,2019-08-06 07:16:48+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,2367000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,,2019-06-30,2019-08-06 07:16:48+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,43614000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,,2019-06-30,2019-08-06 07:16:48+00:00,,totalassets,Total Assets,=,debit,usd,1315547000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,,2019-06-30,2019-08-06 07:16:48+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,12431000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,,2019-06-30,2019-08-06 07:16:48+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,58912000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,,2019-06-30,2019-08-06 07:16:48+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,7610000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,,2019-06-30,2019-08-06 07:16:48+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,78953000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,,2019-06-30,2019-08-06 07:16:48+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,33719000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,,2019-06-30,2019-08-06 07:16:48+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,33719000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,,2019-06-30,2019-08-06 07:16:48+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,112672000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,,2019-06-30,2019-08-06 07:16:48+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,,2019-06-30,2019-08-06 07:16:48+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,,2019-06-30,2019-08-06 07:16:48+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,2496656000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,,2019-06-30,2019-08-06 07:16:48+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1294956000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,,2019-06-30,2019-08-06 07:16:48+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-400000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,,2019-06-30,2019-08-06 07:16:48+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,1575000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,,2019-06-30,2019-08-06 07:16:48+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1202875000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,,2019-06-30,2019-08-06 07:16:48+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1202875000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,,2019-06-30,2019-08-06 07:16:48+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1202875000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,,2019-06-30,2019-08-06 07:16:48+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1315547000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,,2019-09-30,2019-11-12 07:16:42+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,259181000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,,2019-09-30,2019-11-12 07:16:42+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,863069000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,,2019-09-30,2019-11-12 07:16:42+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,30413000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,,2019-09-30,2019-11-12 07:16:42+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1152663000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,,2019-09-30,2019-11-12 07:16:42+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,9365000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,,2019-09-30,2019-11-12 07:16:42+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,39332000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,,2019-09-30,2019-11-12 07:16:42+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,2367000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,,2019-09-30,2019-11-12 07:16:42+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,41699000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,,2019-09-30,2019-11-12 07:16:42+00:00,,totalassets,Total Assets,=,debit,usd,1203727000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,,2019-09-30,2019-11-12 07:16:42+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5041000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,,2019-09-30,2019-11-12 07:16:42+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,78127000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,,2019-09-30,2019-11-12 07:16:42+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,7788000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,,2019-09-30,2019-11-12 07:16:42+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,90956000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,,2019-09-30,2019-11-12 07:16:42+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,31700000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,,2019-09-30,2019-11-12 07:16:42+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,31700000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,,2019-09-30,2019-11-12 07:16:42+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,122656000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,,2019-09-30,2019-11-12 07:16:42+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,,2019-09-30,2019-11-12 07:16:42+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,,2019-09-30,2019-11-12 07:16:42+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,2554608000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,,2019-09-30,2019-11-12 07:16:42+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1474914000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,,2019-09-30,2019-11-12 07:16:42+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-400000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,,2019-09-30,2019-11-12 07:16:42+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,1777000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,,2019-09-30,2019-11-12 07:16:42+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1081071000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,,2019-09-30,2019-11-12 07:16:42+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1081071000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,,2019-09-30,2019-11-12 07:16:42+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1081071000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,,2019-09-30,2019-11-12 07:16:42+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1203727000.0
